HUP0101947A2 - Tumorok kezelésére szolgáló kombinációs készítmény - Google Patents

Tumorok kezelésére szolgáló kombinációs készítmény

Info

Publication number
HUP0101947A2
HUP0101947A2 HU0101947A HUP0101947A HUP0101947A2 HU P0101947 A2 HUP0101947 A2 HU P0101947A2 HU 0101947 A HU0101947 A HU 0101947A HU P0101947 A HUP0101947 A HU P0101947A HU P0101947 A2 HUP0101947 A2 HU P0101947A2
Authority
HU
Hungary
Prior art keywords
combination
tumors
treatment
gastrin
dependent
Prior art date
Application number
HU0101947A
Other languages
English (en)
Inventor
Philip C. Gevas
Stephen Grimes
Stephen L. Karr
Dov Michaeli
Susan A. Watson
Original Assignee
Aphton Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aphton Corporation filed Critical Aphton Corporation
Publication of HUP0101947A2 publication Critical patent/HUP0101947A2/hu
Publication of HUP0101947A3 publication Critical patent/HUP0101947A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2207—Gastrins; Cholecystokinins [CCK]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

A találmány gasztrinfüggő tumorellenes terápiás hatóanyag-kombinációravonatkozik, amely i) egy gasztrinfüggő tumoros növekedésellenesimmunogént és ii) egy vagy több kemoterápiás anyagot tartalmaz. Ó
HU0101947A 1998-05-15 1999-05-14 Combination for the treatment of tumors HUP0101947A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8568798P 1998-05-15 1998-05-15
PCT/US1999/010750 WO1999059628A2 (en) 1998-05-15 1999-05-14 Combination therapy for the treatment of tumors

Publications (2)

Publication Number Publication Date
HUP0101947A2 true HUP0101947A2 (hu) 2001-11-28
HUP0101947A3 HUP0101947A3 (en) 2001-12-28

Family

ID=22193286

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0101947A HUP0101947A3 (en) 1998-05-15 1999-05-14 Combination for the treatment of tumors

Country Status (16)

Country Link
EP (1) EP1076561B1 (hu)
JP (1) JP2002515457A (hu)
KR (1) KR100699574B1 (hu)
CN (1) CN1216605C (hu)
AT (1) ATE291918T1 (hu)
AU (1) AU745749B2 (hu)
CA (1) CA2327439C (hu)
DE (1) DE69924483T2 (hu)
DK (1) DK1076561T3 (hu)
ES (1) ES2237103T3 (hu)
HK (1) HK1032360A1 (hu)
HU (1) HUP0101947A3 (hu)
PL (1) PL193109B1 (hu)
PT (1) PT1076561E (hu)
WO (1) WO1999059628A2 (hu)
ZA (1) ZA200005962B (hu)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2441228A1 (en) * 2001-03-23 2002-10-03 Aphton Corporation Combination treatment of pancreatic cancer
US20030021786A1 (en) * 2001-07-09 2003-01-30 Gevas Philip C. Treatment and prevention of cancerous and pre-cancerous conditions of the liver, lung and esophagus
KR20050025306A (ko) * 2002-07-03 2005-03-14 애프톤 코포레이션 리포좀 백신
WO2004088326A2 (en) 2003-03-28 2004-10-14 Aphton Corporation Gastrin hormone immunoassays
US20050053664A1 (en) * 2003-09-08 2005-03-10 Eliezer Zomer Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer
US8674064B2 (en) 2010-03-03 2014-03-18 Onkologix Ltd Immunogenic compositions against human progastrin peptides
CN101797382B (zh) * 2010-03-03 2013-11-20 戚胜美 抗人前胃液素多肽免疫组合物
EA017179B1 (ru) * 2011-04-06 2012-10-30 Ооо "Метамакс" Фармацевтическая композиция для лечения гиперпролиферативных заболеваний и её применение
JP6502939B2 (ja) 2013-11-22 2019-04-17 シーエル バイオサイエンシズ リミティド ライアビリティ カンパニー 骨粗鬆症の処置及び予防のためのガストリン拮抗薬
WO2018232230A1 (en) 2017-06-15 2018-12-20 Cancer Advances Inc. Compositions and methods for inducing humoral and cellular immunities against tumors and cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341281C (en) * 1986-07-09 2001-08-07 Hubert J.P. Schoemaker Immunotherapy of tumor with monoclonal antibody against the 17-1a antigen
DE69014137T2 (de) * 1989-01-24 1995-06-08 Aphton Corp Immunogenische Zusammensetzungen gegen Gastrin-Peptide.
US5468494A (en) * 1993-11-12 1995-11-21 Aphton Corp. Immunogenic compositions against human gastrin 17

Also Published As

Publication number Publication date
PT1076561E (pt) 2005-08-31
EP1076561B1 (en) 2005-03-30
KR100699574B1 (ko) 2007-03-23
PL344414A1 (en) 2001-11-05
AU3904599A (en) 1999-12-06
ZA200005962B (en) 2002-01-24
WO1999059628A3 (en) 2000-01-13
KR20010052355A (ko) 2001-06-25
CN1303288A (zh) 2001-07-11
DE69924483T2 (de) 2006-02-09
DE69924483D1 (de) 2005-05-04
JP2002515457A (ja) 2002-05-28
WO1999059628A2 (en) 1999-11-25
HUP0101947A3 (en) 2001-12-28
CA2327439A1 (en) 1999-11-25
ES2237103T3 (es) 2005-07-16
HK1032360A1 (en) 2001-07-20
ATE291918T1 (de) 2005-04-15
EP1076561A2 (en) 2001-02-21
DK1076561T3 (da) 2005-06-06
CN1216605C (zh) 2005-08-31
PL193109B1 (pl) 2007-01-31
AU745749B2 (en) 2002-03-28
CA2327439C (en) 2005-07-05

Similar Documents

Publication Publication Date Title
EP0960107A4 (hu)
PL367682A1 (en) Dolastatin 10 derivatives
DK1187632T3 (da) Behandling med anti-ErbB2-antistoffer
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
CY2295B1 (en) Phosphonooxymethyl or methylthiomethyl ethers of taxane derivatives as antitumor agents
NO990789L (no) Cytotoksisk aminosukker og beslektede sukker-derivater av indolopyrrolokarbazoler
ATE231872T1 (de) Thiazolopyrimidinderivate
ES2056180T3 (es) Nuevos derivados de 2'-halometiliden, 2'-eteniliden y 2'-etinil citidina.
HUP0300848A2 (hu) Kamptotecint és egy pirimidinszármazékot tartalmazó készítmény rák kezelésére
NO20005885L (no) Kombinasjonsterapi for behandling av refraktær depresjon
MX9601994A (es) Profarmacos de derivados de paclitaxel.
HUP0101947A2 (hu) Tumorok kezelésére szolgáló kombinációs készítmény
EE03771B1 (et) Tetrahüdropüridoühendid, neid sisaldav ravim ja nende kasutamine
HUP0104413A2 (hu) Ascomycineket tartalmazó helyi készítmények
ATE240303T1 (de) 1,2,4-triazol-3-thion verbindungen
HUP9802423A2 (hu) Hiperproliferatív megbetegedések kombinált gyógyászati kezelése
NO983177L (no) Anvendelse av 1-enantiomeren av centkroman til fremstilling av et farmasaytisk preparat for behandling eller profylakse av brystkreft
HUP0203906A2 (en) Aplidine treatment of cancers
HUP0301247A2 (hu) Antitumor terápia disztamicin származékokkal
AU3439799A (en) Immunization against and treatment for infection by (h.pylori)
AP2001002369A0 (en) Pharmaceutical complex.
BG106534A (en) Oral solution containing galanthamine and a sweetening agent
DE69818492D1 (en) 7-methylthiooxomethyl- und 7-methylthiodioxomethyl-paclitaxele
NO985068D0 (no) Vaksiner for behandling av lymfom og leukemi
IL138117A0 (en) 5-imino-13-deoxy anthracycline derivatives, their uses and processes for preparing them

Legal Events

Date Code Title Description
FH91 Appointment of a representative

Free format text: FORMER REPRESENTATIVE(S): SZENTPETERI ZSOLT, S.B.G. & K. SZABADALMI UEGYVIVOEI IRODA, HU

Representative=s name: SZENTPETERI ZSOLT, S.B.G. & K. SZABADALMI UEGY, HU

FH92 Termination of representative

Representative=s name: SZENTPETERI ZSOLT, S.B.G. & K. SZABADALMI UEGY, HU

GB9A Succession in title

Owner name: RECEPTOR BIOLOGIX, INC., US

Free format text: FORMER OWNER(S): APHTON CORPORATION, US